The global Organ Preservation Market will reach USD 300 million in 2028. It is expected to grow at 6.3% annually for the period 2022-2028.
Organ preservation refers to the safe transport and storage of organs from donors in order to facilitate transplantation. These can be hypothermic, normothermic or static cold storage. These organ preservation techniques are vital for organ quality. These methods are essential for organ quality. These techniques are used extensively in healthcare around the globe. It is called delayed graft function (DGF) or primary nonfunction (PNF) when an organ fails to recover after reperfusion or implantation surgery. Other growth-inducing factors include the increasing incidence of organ dysfunctions caused by obesity and diabetes. Global market trends are favorable due to the increasing preference for normothermic machine preservation methods. These help lower the risk and improve cold storage. Organ preservation methods include machine perfusion, in situ core cooling, and organ preservation liquids.
Traditional methods for organ preservation include maximising donor hemodynamics, better surgical procurement techniques that minimize dissection of vascular structures, as well as removing abdominal organs in an unbroken fashion with the seperation of graft parts. Hyperkalemic hyperosmolar solutions are kept at 4 degrees Celsius for cold storage. The donor or recipient can then be treated pharmacologically. Before the organs are removed from donors, they are cleaned with an ice cold preservation solution that contains nutrients and electrolytes. Before being shipped to the recipient’s transplant centre, the organs are placed into sterilized containers. It is important to get the organs from the donor to the recipient as quickly as possible. The heart and lungs must be removed from the donor within four hours. Your lungs can be preserved for up to 12 hours. You can also preserve your pancreas for between 8-12 hours. You can preserve your intestines for up to 8 hours. You can keep your kidneys for up to 24 hours.
The Organ Preservation report analyzes market segmentation forecasts, by solution, organ type, region, and technique. This report provides detailed information about the industry’s profit and offers a SWOT analysis to analyze market trends and identify significant competitors. It also includes a study of the market geographically.
Key Market Participants:
Bristol-myers Squibb. Xvivo Perfusion AB. Paragonix Technologies. Franz Kohler Chemie Gmbh. Biolife Solutions Inc. Claris Lifesciences Limited. Lifeline Scientific. Tolerotech Inc.
(Note: For a complete list of important players, please visit the report page.
The Organ Preservation Market’s global overview can be divided into North America and Europe, Latin America and Asia-Pacific as well as the Middle East and Africa.
North America dominated the market for 2019, and it will continue to do so over the forecast period. The growth is due to the acceptance of new healthcare technologies, high rates of chronic heart disease and heart disease, as well as improved reimbursement policies and investments in healthcare infrastructure. A growing geriatric population will support the regional market as well as increased organ transplantation procedures. Asia Pacific will experience the fastest growth over the forecast period, due to increasing healthcare spending, patient awareness and growing demand for transplantation procedures. Market growth will also be driven primarily by rising aging populations, increasing incidence of heart disease, kidney failure, and rising healthcare spending.
Objectives for the Study:
- This report will provide an in-depth analysis of the Organ Preservation Market, by solution, organ type, region, and technique.
- To provide detailed statistics and data points about market-moving elements (drivers and opportunities)
- To assess and forecast micro-markets, as well as the whole market.
- Forecast market trends, size and overview in key regions, including North America, Europe and Asia Pacific.
- To keep up to date with the competitive environment (including new product launches and mergers and acquisitions) and to evaluate them.